Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 3Unknown 1

Sponsor Class

OTHER 1NIH 1NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3

Conditions

Sarcoma, Kaposi 2Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1AIDS-related Kaposi sarcoma 1

Interventions

Cyclophosphamide 739Cisplatin 687Gemcitabine 641Bevacizumab 615Carboplatin 604Paclitaxel 600Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 360Capecitabine 342Filgrastim 333Etoposide 328Dexamethasone 312Irinotecan 309pembrolizumab 279Leucovorin 274Cetuximab 267Cytarabine 242Erlotinib Hydrochloride 231Prednisone 227Nivolumab 227Trastuzumab 225Bortezomib 221Vincristine 220Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Completed × Indinavir × Clear all
NCT00003008 2023-06-15

Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma

Eastern Cooperative Oncology Group

Phase 2 Completed
33 enrolled
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Sarcoma, Kaposi

NCT01067690 2016-08-30

Treatment With Indinavir and Chemotherapy for Advanced Classical Kaposi's Sarcoma

Istituto Superiore di Sanità

Phase 2 Completed
25 enrolled
Sarcoma

Sarcoma, Kaposi

NCT00001566 2012-06-15

A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
42 enrolled 16 charts
Sarcoma

Rhabdomyosarcoma, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡